← Back to Patent Explorer
US3980696A Expired / Lapsed US ⏱️ 0.0 years remaining

Photodosimeter film badge

Assignee: Beckman Coulter Inc
•
Filing: 1974-07-25
•
Granted: 1976-09-14
•
Expires: 1994-07-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A film badge sensitive to non-ionizing radiation and a method of making same. The film badge consists of dissolved bilirubin bound in a polymeric film base and sealed within an optically transparent substrate. The film badge is useful during phototherapy for the treatment of hyperbilirubinemia in the newborn and is capable of measuring the total irradiance effective in decomposing bilirubin.

Inventors

  • 👤 Robert J. Anderson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 19:27
CPC Classifications
G; G03; G03C; G03C1/00; G03C1/72; G03C1/73; G03C1/731; B; B32; B32B; B32B27/00; B32B27/18; Y; Y10; Y10S; Y10S436/00; Y10S436/902; Y10T; Y10T156/00; Y10T156/10; Y10T156/1052; Y10T156/1062; Y10T428/00; Y10T428/31504; Y10T428/31507; Y10T428/31786; Y10T428/31797; Y10T428/31855; Y10T428/31909; Y10T428/31913; Y10T428/31928; Y10T428/31971; Y10T436/00; Y10T436/10; Y10T436/103332; Y10T436/14; Y10T436/145555; Y10T436/146666

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 103 words
A dosimeter for use in the treatment of hyperbilirubinemia by phototherapy comprising: a. a thin film of uniform thickness comprising dissolved bilirubin bound in a polymeric base, said bilirubin being substantially only the IX-alpha isomer thereof in sufficient concentration to cause a detectable change in the optical density of said film upon exposure to light having a wavelength of about 425-500 nanometers; and, b. an optically transparent substrate impervious to the passage of oxygen and sealing said film whereby oxygen is excluded from contacting said film while light striking said film will cause photodecomposition of the bilirubin without transforming the bilirubin into biliverdin.
Claim 2
Dependent Claim 103 words
A dosimeter for use in the treatment of hyperbilirubinemia by phototherapy comprising: a. a thin film of uniform thickness comprising dissolved bilirubin bound in a polymeric base, said bilirubin being substantially only the IX-alpha isomer thereof in sufficient concentration to cause a detectable change in the optical density of said film upon exposure to light having a wavelength of about 425-500 nanometers; and, b. an optically transparent substrate impervious to the passage of oxygen and sealing said film whereby oxygen is excluded from contacting said film while light striking said film will cause photodecomposition of the bilirubin without transforming the bilirubin into biliverdin.
Claim 3
Dependent Claim 19 words
The dosimeter of claim 1 wherein said substrate comprises two pieces of optically transparent material sealing said film therebetween.
Claim 4
Dependent Claim 28 words
A dosimeter according to claim 1 having an action spectrum which is the same as the action spectrum for the photodecomposition of serum bilirubin in the human body.
Claim 5
Dependent Claim 34 words
A dosimeter according to claim 3 wherein the kinetics of the change in optical density of said film badge is similar to the kinetics of the photodecomposition of serum bilirubin in the human body.
Claim 6
Dependent Claim 18 words
A dosimeter according to claim 1 wherein said polymeric film base is a copolymer of acrylic with melamine.
Claim 7
Dependent Claim 14 words
A dosimeter according to claim 1 wherein said polymeric base is polycarbonate or phenoxy.
Claim 8
Dependent Claim 12 words
A dosimeter according to claim 1 wherein said polymeric base is polystyrene.
Claim 9
Dependent Claim 17 words
A dosimeter according to claim 1 wherein said polymeric base is a copolymer of styrene and methylmethacrylate.
Claim 10
Dependent Claim 14 words
A dosimeter according to claim 1 wherein said polymeric base is ethylene-vinyl acetate copolymer.
Claim 11
Dependent Claim 13 words
A dosimeter according to claim 1 wherein said polymeric base is polymethyl methacrylate.

References Cited (Backward Citations)

US2854317A Cited
US3092465A Cited
US3420635A Cited
US3502437A Cited
US3552929A Cited
US3853476A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-09-14 1980-03-15 1980-09-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-09-14 1984-03-15 1984-09-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-09-14 1988-03-15 1988-09-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag